MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4962 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-03-20 (bangordailynews.com)
Maine DEP says Mallinckrodt isn't cleaning up toxic Orrington site fast enough
Mercury pollution at the site originated with the HoltraChem Manufacturing Co., which operated from 1967 to 1982.
Read more
2024-05-31 (biospectrumasia.com)
MedTech’s sustainability mission
MedTech’s sustainability mission
Read more
2023-12-04 (massdevice.com)
Aptar wins FDA contract to study low global warning potential metered dose inhalers
Aptar Pharma announced today that it entered into a contract with the FDA to work on low global warming potential (low-GWP) inhalers.
Read more
2023-11-03 (investingnews.com)
Medtronic: Helping Lead the Way in Packaging Waste Reduction
MedtronicGlobally, less than 15% of waste gets recycled each year. Even more staggering, less than 1% of medical waste gets recycled. * As part of our commitment to operate sustainably, Medtronic is working to set an example for how our industry can reduce waste generated from the packaging of
Read more